Huang Yu, Xu Hongchun, Xiang Feng, Feng Wei, Ma Yuchao, Jin Longyu
Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, China.
Int J Emerg Med. 2025 Feb 28;18(1):38. doi: 10.1186/s12245-025-00835-1.
Non-steroidal anti-inflammatory drugs (NSAIDs) are increasingly utilized in trauma patients, particularly those with critical chest trauma who are susceptible to significant blood loss, leading to renal hypoperfusion. Acute kidney injury (AKI) is known to carry a poor prognosis in chest trauma patients. Therefore, investigating the potential association between NSAID use and AKI risk in critical patients with chest trauma is crucial.
We selected patients admitted to the intensive care unit (ICU) with chest trauma from the Medical Information Mart for Intensive Care III (MIMIC-III) dataset (2001-2012) and the Medical Information Mart for Intensive Care IV (MIMIC-IV) dataset (2013-2019). Propensity score matching (PSM) was used to match patients receiving NSAIDs with those not receiving treatment. Logistic regression was employed to assess the association between different types of NSAIDs and AKI in these patients.
In MIMIC-IV, NSAID use significantly increased the risk of AKI in critical patients with chest trauma (OR 1.99; 95% CI 1.04 to 3.85). Subgroup analysis revealed that aspirin significantly increased AKI risk in both MIMIC-III (OR 1.81; 95% CI 1.02 to 3.2) and MIMIC-IV (OR 2.47; 95% CI 1.26 to 4.85). However, ibuprofen and ketorolac use were not associated with AKI in these patients.
We observed a significant association between aspirin use and an elevated risk of AKI in critical patients with chest trauma. These findings suggest that pain management strategies involving ibuprofen and ketorolac may be more appropriate for this patient population.
非甾体抗炎药(NSAIDs)在创伤患者中应用越来越广泛,尤其是那些胸部严重创伤且易发生大量失血导致肾灌注不足的患者。已知急性肾损伤(AKI)在胸部创伤患者中预后较差。因此,研究NSAIDs使用与胸部创伤重症患者AKI风险之间的潜在关联至关重要。
我们从重症医学信息数据库III(MIMIC - III)数据集(2001 - 2012年)和重症医学信息数据库IV(MIMIC - IV)数据集(2013 - 2019年)中选取入住重症监护病房(ICU)的胸部创伤患者。采用倾向评分匹配(PSM)将接受NSAIDs治疗的患者与未接受治疗的患者进行匹配。运用逻辑回归评估这些患者中不同类型NSAIDs与AKI之间的关联。
在MIMIC - IV中,使用NSAIDs显著增加了胸部创伤重症患者发生AKI的风险(比值比1.99;95%置信区间1.04至3.85)。亚组分析显示,阿司匹林在MIMIC - III(比值比1.81;95%置信区间1.02至3.2)和MIMIC - IV(比值比)中均显著增加了AKI风险。然而,在这些患者中使用布洛芬和酮咯酸与AKI无关。
我们观察到在胸部创伤重症患者中,使用阿司匹林与AKI风险升高之间存在显著关联。这些发现表明,对于该患者群体,涉及布洛芬和酮咯酸的疼痛管理策略可能更为合适。